Search results
Showing results for
On Monday, 24 July the Department of Oncology will welcome 27 students from across the UK who will gather in Oxford to find out what it would be like to study here.
Forging New Pathways in Oncology: Strategic Insights from the 17th Annual Frontiers in Cancer Science Conference.
Journal article
Huang D. et al, (2026), Cancer Res, 86, 3106 - 3108
CDIN1-Codanin-1 complex defective in congenital dyserythropoietic anaemia type I is an RNA nuclease.
Conference paper
Brolih S. et al, (2026), Nat Commun
Tirapazamine sensitises hypoxic homologous recombination-proficient NSCLC to PARP inhibition.
Journal article
Jiang Y. et al, (2026), Cell Death Discov
Addition of rituximab to first-line treatment of Burkitt lymphoma in children and young adults in Tanzania: a cost-utility analysis
Journal article
MORRELL L. et al, (2026), Journal of Clinical Oncology Global Oncology
Diagnostic Implications of Multi-Cancer Early Detection Testing in the Investigation of Cancer Symptoms: An Exploratory Retrospective Analysis of the SYMPLIFY Study.
Journal article
Jackson A. et al, (2026), Lancet Reg Health Eur, 66
Current status of radionuclide therapy targeting PARP in cancer: challenges and prospects.
Journal article
Kurniawan A. et al, (2026), Eur J Nucl Med Mol Imaging
CT radiomics for survival risk stratification in resectable colorectal liver metastases: a multi-centre study.
Journal article
Mian A. et al, (2026), Sci Rep, 16
A multi-center clinical evaluation on first-in-class ROP-based IGRA for tuberculosis diagnosis.
Journal article
Li Q. et al, (2026), iScience, 29
Pragmatism in academic gastrointestinal cancer clinical trials: An analysis of trials conducted by the EORTC gastrointestinal tract cancer group and the unicancer gastrointestinal group.
Journal article
Puhr HC. et al, (2026), Eur J Cancer, 241
Supplementary Table 7 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Table 2 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Figure 4 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Text 1 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Figure 2 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Table 1 from The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
Other
Hashimoto T. et al, (2026)
Supplementary Table 3 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Table 8 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Table 3 from The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
Other
Hashimoto T. et al, (2026)